Project Grant R01MH134993

Award Date 7/5/24
Completion Date 1/31/29
Dollars Obligated $2.2M
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Cambridge, MA 02138, USA
Similar Awards
This federal Project Grant award of $446,126 from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to develop a new bioassay to study astrocyte borders and profile their functional states in the context of diverse non-neural cell populations. The key objectives are to optimize the bioassay by combining injectable cellulose-based hydrogels with viral vectors to...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under CFDA 93.310 - Trans-NIH Research Support program totals $1,490,348 and is aimed at testing an integrative hypothesis about the role of astrocytes in the brain's neuromodulator signaling systems. The award, made to the Research Foundation For Mental Hygiene, Inc. (RFMH) doing business as the New York Psychiatric Center, will utilize state-of-the-art cellular imaging and spatial transcriptomics...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $1,270,816 to Yale University to conduct research on the gene regulatory networks that control the development and function of radial glia cells, the stem cells of the human brain. The 5-year project aims to decipher the transcriptional networks and external signals that regulate...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $452,550 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to investigate the role of reactive astrogliosis in Alzheimer's disease-related synaptic dysfunction and loss. The key objectives are to determine how astrocyte upregulation of the GFAP protein, a hallmark of reactive astrogliosis in Alzheimer's, impacts the structure and proteome of...
This federal Project Grant award of $361,975.00 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program will support the development of chemical probes to visualize and manipulate astrocytes, the brain's support cells, and their interactions with neurons. The funded research aims to expand on the awardee's preliminary work in designing chemical tags that can...
This $682,470 Project Grant award from the National Institute of Mental Health (CFDA 93.242 - Mental Health Research Grants) supports research by the University of California, Los Angeles (UCLA) to elucidate the regulation of cell fate specification in the development of the human cortex. The goal is to better understand the etiology of neurodevelopmental disorders. The research will leverage recent advances in single-cell characterizations of the developing human cortex to identify novel...
This $1,008,977 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, supports research to understand human brain development and the origins of neurodevelopmental diseases. The award aims to study two recently discovered neural progenitor cell types found in the outer subventricular zone of the developing human brain, which are key...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $136,309 to the University of California, Irvine (UC Irvine) from September 30, 2024 to August 31, 2026. The funding supports research to investigate the role of dysfunctional astrocyte development and maturation in the onset and progression of Huntington's disease (HD)....
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $522,500.00 to The Salk Institute for Biological Studies to conduct research aimed at understanding the role of astrocytes, a type of non-neuronal brain cell, in contributing to age-related motor and cognitive decline. The key objectives are to determine if the transcription factor STAT1 drives age-related changes in cerebellar astrocytes, and whether modulating STAT1 can prevent or rescue...
This $195,896 Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program supports research to define the cellular connectivity and circuitry between glioblastoma brain tumor cells and diverse neuronal populations in a mouse model. The key objectives are to: Map the whole-brain neuronal inputs onto patient-derived glioblastoma organoids...

UNDERSTANDING GLIAL FATE RESTRICTION IN HUMANS - ABSTRACT THIS PROPOSAL AIMS TO DETERMINE THE MECHANISMS THAT LEAD TO THE GENERATION OF ASTROCYTES IN THE DEVELOPING HUMAN CORTEX. ASTROCYTES ARE THE MOST ABUNDANT CELL TYPE IN THE ADULT HUMAN BRAIN, MEDIATING VITAL FUNCTIONS INCLUDING MYELINATION, AXONAL GUIDANCE, SYNAPTOGENESIS, AND MAINTENANCE OF THE BLOOD-BRAIN BARRIER. DURING DEVELOPMENT, CONTROL OVER THE SPATIO-TEMPORAL PATTERNS OF THE PRODUCTION AND NUMBERS OF ASTROCYTES IS NECESSARY FOR PROPER BRAIN FUNCTION. THE DEVELOPMENTAL POTENTIAL OF NEOCORTICAL PROGENITORS EXHIBITS EVOLUTIONARY DIVERGENCE ACROSS MAMMALIAN CLADES, LEADING TO PRIMATE-SPECIFIC CELL TYPES, SUCH AS INTERLAMINAR ASTROCYTES. PROGRESS IN STUDYING HUMAN ASTROCYTIC DEVELOPMENT IS LIMITED BY THE ETHICAL AND PRACTICAL CHALLENGES IN WORKING WITH HUMAN FETAL TISSUE AND FUNDAMENTAL DIFFERENCES BETWEEN MAMMALIAN MODELS AND HUMANS. CONSEQUENTLY, HOW THE DEVELOPMENTAL POTENTIAL OF PROGENITOR CELLS OF THE CORTEX IS RESTRICTED TO GENERATE ASTROCYTES REMAINS UNKNOWN. ADDRESSING THIS QUESTION IS ESSENTIAL FOR UNDERSTANDING HUMAN BRAIN DEVELOPMENT AND WILL LAY THE FOUNDATION FOR UNCOVERING THE CAUSES AND DEVISING NEW TREATMENT STRATEGIES FOR ASTROCYTE-RELATED HUMAN DISEASES IN MOUSE, ASTROCYTIC PROGENITORS ARISE ONLY AFTER CORTICAL NEURONS FROM THE SIX LAYERS ARE GENERATED. THE COMMON HYPOTHESIS WAS THAT, SIMILARLY, ASTROCYTES ARISE FROM OUTER RADIAL GLIA IN HUMANS IN THE SECOND TRIMESTER OF DEVELOPMENT AFTER THE LAYERS OF THE CORTEX ARE ALREADY FORMED. PRELIMINARY WORK OBTAINED THROUGH THE ANALYSIS OF SINGLE-CELL GENE EXPRESSION DATA FROM THE DEVELOPING HUMAN CORTEX, IN VITRO EMBRYONIC STEM CELL EXPERIMENTS, AND IN VITRO TO IN VIVO MAPPING SHOWS THAT THE ASTROCYTIC LINEAGE IN HUMANS ARISES VERY EARLY BEFORE THE CORTICAL LAYERS ARE FORMED AND LIKELY FROM THE NEUROEPITHELIUM OF THE FOREBRAIN. COMPUTATIONAL ANALYSIS OF THE FETAL TISSUE SINGLE-CELL EXPRESSION DATA AND PRELIMINARY EXPERIMENTS IMPLICATE CELL-TO-CELL CONTACT-DEPENDENT SIGNALING THROUGH YAP AND NOTCH PATHWAYS IN DETERMINING THE ASTROGLIOGENIC FATE OF THE PROGENITORS. FURTHER, PRELIMINARY COMPUTATIONAL ANALYSES OF HUMAN FETAL DATA IDENTIFY CRITICAL TRANSCRIPTION FACTORS INVOLVED IN THIS FATE DECISION. THE PROPOSAL AIMS TO DETERMINE THE DEVELOPMENTAL POTENTIAL AND THE LINEAGE DECISIONS OF THE NEWLY IDENTIFIED ASTROGLIOGENIC PROGENITORS OVER 9 MONTHS. THIS WILL BE ACCOMPLISHED BY TRACING THE LINEAGE DECISIONS OF PROGENITORS IN THE VALIDATED IN VITRO SYSTEM USING VIRAL BAR-CODED VIRAL LIBRARIES AND CLONAL ANALYSES AND MAPPING THE RESULTS, THROUGH DATA ANALYSIS, ONTO IN VIVO HUMAN FETAL DATA AS WELL AS THROUGH IMMUNOSTAINING OF CRYOSECTIONED FETAL TISSUE OBTAINED AT DIFFERENT TIME POINTS. THE PROPOSAL FURTHER AIMS TO DETERMINE THE ROLE OF YAP AND NOTCH SIGNALING AND THE COMPUTATIONALLY IMPLICATED TRANSCRIPTION FACTORS IN GENERATING THESE NEWLY IDENTIFIED PROGENITORS. THIS IS ACCOMPLISHED THROUGH NOVEL HUMAN EMBRYONIC STEM CELL LINES AND LIVE IMAGING TO MONITOR THE DYNAMICS OF THESE SIGNALING PATHWAYS, CHEMICAL, AND GENETIC PERTURBATIONS THAT ALLOW MODULATION OF PATHWAY ACTIVITY, AND INDUCIBLE CRISPRI TO KNOCK DOWN SPECIFIC GENES WHILE MONITORING THEIR EFFECTS ON THE GENERATION AND PATTERNING OF THE PROGENITORS.

Posted 7/5/24, 12:00 AM